Diagnosis
Crohn disease
Inflammatory bowel disease characterized by transmural inflammation involving any part of the GI tract (usually small intestine and proximal colon).
Also known as: Granulomatous enteritis, IBD, Inflammatory bowel disease, Morbus Crohn, Terminal ileitis
Etiology
Cause [4d0][mze]
The exact cause remains unknown
Possible explanation:
Inappropriate immune response to environmental antigens like drugs, toxins, infections, or intestinal microbes in a genetically susceptible host
An imbalance between proinflammatory and anti-inflammatory mediators
Pathophysiology [4d0]
T-cell activation, Interleukin-12 and TNF-alpha --> Chronic granulomatous inflammation from --> injury to the intestine --> fever/malaise, diarrhea, abdominal pain
Transmural inflammation --> thickening of the bowel wall and narrowing of the lumen
Complications [4d0][mze]
Obstruction
Deep ulceration
Fistulization
Abscess formation
Adhesions
Malabsorption
Terminal ileitis --> malabsorption, vitamin B12 insufficiency --> anemia
Colorectal carcinoma
Extraintestinal manifestations:
Eyes: episcleritis, scleritis, uveitis
Mouth: stomatitis, aphthous ulcers
Liver: cholelithiasis, cholangitis, primary sclerosing cholangitis
Kidneys: nephrolithiasis, hydronephrosis, urinary tract infection
Joints: ankylosing spondylitis, peripheral arthritis (knees, ankles, wrists, elbows)
Skin: erythema nodosum and pyoderma gangrenosum
Epidemiology
Incidence per 100.000 [du9][4d0][hoh][kcs][zsn]
Prevalence per 100.000 [du9][4d0][hoh][kcs][zsn]
Symptoms & findings
Symptoms
Anal fissure, Anorectal abscess, Anorectal fistula, Arthralgia, Diarrhea, Dyschezia, Fatigue, Fever, Fistula, Hematochezia, Hyperactive bowel sounds, Ileus, Melena, Nausea, Tachycardia, Tachypnea, Vomiting, Weight loss
Clinical findings
Acidosis, Elevated CRP, Elevated Sedimentation Rate, Gastrointestinal dilatation, Gastrointestinal stenosis, Hydronephrosis, Leukocytosis, Necrotizing granuloma, Peritonitis, Scleritis, Stomatitis, Uveitis
Anamneses
None listed.
Localized findings
Approach
Blood test: complete blood count, metabolic panel, vitamin B12, iron, electrolytes, creatinine, liver enzymes, antibodies (ANCA), CRP, erythrocyte sedimentary rate
Stool test: culture, C. difficile toxin, calprotectin
Urinalysis: bacteriuria and leukocyturia
Blood gas
Colonoscopy + biopsy: The golden standard
CT abdomen
Treatment
Treatment based on the disease site, pattern, activity, and severity. Treatment goal is to achieve best possible clinical, laboratory, and histologic control with the least adverse effects from medication. [4d0][mze]
Mild disease:
5-aminosalicylic acid (5-ASA)
Moderate disease:
Corticosteroid (not preferred for maintenance due to side effects)
Inhibitors of DNA synthesis (immunomodulators): azathioprine or methotrexate
Severe disease:
Biologic agents (anti-TNF) after tuberculosis and hepatitis B virus is excluded
5-ASA, corticosteroid, and/or immunomodulators
Surgical resection if hemorrhage, stenosis, perforation, abscess, fistula, cancer, and toxic megacolon
Other: Antibiotics (anal fistula), loperamide (chronic diarrhea), bile acid binders (for bile acid diarrhea), low-fat diet (defective bile salt absorption -> steatorrhea)
Differential diagnoses
Abdominal abscess, Acute mesenteric ischemia, Adhesion, Amebiasis, Anal fissure, Anorectal abscess, Anorectal fistula, Appendicitis, Arthritis, Behcet's disease, Benign neoplasm of the small intestine, Carcinoid tumor, Celiac disease, Cholelithiasis, Coccidioidomycosis, Cytomegalovirus, Diverticulitis, Drug side effects, Erythema nodosum, Femoral hernia, Foreign body, Gastroenteritis, Giardiasis, Histoplasmosis, Incisional hernia, Infectious colitis, Inguinal hernia, Intussusception, Iridocyclitis, Irritable bowel syndrome, Ischemic colitis, Lymphoma, Meckels diverticulum, Ovarian torsion, Peritonitis, Peutz-Jeghers syndrome, Primary sclerosing cholangitis, Pseudomembranous colitis, Pyoderma gangrenosum, Ruptured ectopic pregnancy, Salmonellosis, Sarcoidosis, Shigellosis, Small bowel cancer, Tuberculosis, Ulcerative colitis, Umbillical hernia, Yersinia enterocolitica
References
[1] http://emedicine.medscape.com/article/172940 (2014-01-02); [Medscape]
[2] Ranasinghe IR, Tian C, Hsu R. Crohn Disease. [Updated 2024 Feb 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK436021/
[3] GBD 2017 Inflammatory Bowel Disease Collaborators. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020 Jan;5(1):17-30.
[4] Choe YJ, Han K, Shim JO. Treatment patterns of anti-tumour necrosis factor-alpha and prognosis of paediatric and adult-onset inflammatory bowel disease in Korea: a nationwide population-based study. Aliment Pharmacol Ther. 2022 Sep;56(6):980-988.
[5] Shivashankar R, Tremaine WJ, Harmsen WS, Loftus EV Jr. Incidence and Prevalence of Crohn's Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010. Clin Gastroenterol Hepatol. 2017 Jun;15(6):857-863.
[6] Busingye D, Pollack A, Chidwick K. Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study. PLoS One. 2021 May 27;16(5):e0252458.